hématologie et oncologie
Syndrome hyperéosinophilique
Références générales
1.Apperley JF, Gardembas M, Melo JV, et al: Response toimatinib mesylatein patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta.N Engl J Med347:481–487, 2002. 2.Shomali W, Gotlib J: World Health Organization-defined eosinophilic disorders: 2022 update on diagnosis, risk stratification, and management.Am J Hematol97:129–148, 2022. 